Heart Disease Trial, Recruiting NCT05564689 Sponsor: Ashkan Eftekhari Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT05564689
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are over 18 years old
  • Your heart's electrical signal takes longer than usual to travel through the heart (a measurement called QRS of 150 milliseconds or more), measured before your device was put in
  • Your heart failure is caused by a condition where the heart muscle is enlarged and weakened (called dilated cardiomyopathy)
  • Your heart is beating in a normal, regular rhythm (called sinus rhythm)
  • Your heart failure medications have been steady and unchanged for a period of time
  • You have a specific abnormal electrical pattern in your heart called Left Bundle Branch Block (LBBB)
  • You already have a special heart device called a CRT (Cardiac Resynchronisation Therapy) device

Who may not be able to join:

  • Your kidneys are not working well enough (a kidney function score below 30 ml/min) (confirm with trial site)
  • You have serious problems with one or more of your heart valves
  • You have a permanent irregular heart rhythm called atrial fibrillation or atrial flutter
  • You have previously had a procedure to open blocked heart arteries (stenting or bypass surgery)
  • You have previously had a heart attack
  • Your heart failure is caused by reduced blood supply to the heart muscle
  • You already have a different type of heart device, such as a standard pacemaker or a defibrillator (ICD)
  • You are not able to give your agreement to take part in the study
  • You do not understand Danish

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ashkan Eftekhari, Department of Cardiology, Aalborg University Hospital

Phone: 004528973764

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ashkan Eftekhari
Registry
ClinicalTrials.gov
Start date
29 September 2022
Est. completion
30 September 2026

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Absolute coronary flow

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov